Protein kinase C-δ mediates shedding of angiotensin-converting enzyme 2 from proximal tubular cells

Frontiers in Pharmacology

Volumn 7, Issue JUN, 2016, Pages

  Xiao, Fengxia ^a   Zimpelmann, Joseph ^a   Burger, Dylan ^a   Kennedy, Christopher ^a   Hébert, Richard L ^a   Burns, Kevin D ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

ACE2; ADAM17; Diabetes; Kidney; PKC; Renin angiotensin system; Sheddase

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; GLUCOSE; PROTEIN KINASE C DELTA; TRANSFER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; GENETIC TRANSFECTION; IMMUNOBLOTTING; KIDNEY TUBULE CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

EID: 84977654136     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2016.00146     Document Type: Article

References (32)

1. Cherney, D. Z., Xiao, F., Zimpelmann, J., Har, R. L., Lai, V., Scholey, J. W., et al. (2014). Urinary ACE2 in healthy adults and patients with uncomplicated type 1 diabetes. Can. J. Physiol. Pharmacol. 92, 703-706. doi: 10.1139/cjpp-2014-0065
2. Chodavarapu, H., Grobe, N., Somineni, H. K., Salem, E. S., Madhu, M., and Elased, K. M. (2013). Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion. PLoS ONE 8: e62833. doi: 10.1371/journal.pone.0062833
3. Grobe, N., Di Fulvio, M., Kashkari, N., Chodavarapu, H., Somineni, H. K., Singh, R., et al. (2015). Functional and molecular evidence for expression of the renin angiotensin system and ADAM17-mediated ACE2 shedding in COS7 cells. Am. J. Physiol. Cell Physiol. 308, C767-C777. doi: 10.1152/ajpcell.00247.2014
4. Hinkle, C. L., Sunnarborg, S. W., Loiselle, D., Parker, C. E., Stevenson, M., Russell, W. E., et al. (2004). Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency. J. Biol. Chem. 279, 24179-24188. doi: 10.1074/jbc. M312141200
5. Iwata, M., Silva Enciso, J. E., and Greenberg, B. H. (2009). Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor alpha-converting enzyme. Am. J. Physiol. Cell Physiol. 297, C1318-C1329. doi: 10.1152/ajpcell.00036.2009
6. Izumi, Y., Hirata, M., Hasuwa, H., Iwamoto, R., Umata, T., Miyado, K., et al. (1998). A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor. EMBO J. 17, 7260-7272. doi: 10.1093/emboj/17.24.7260
7. Jia, H. P., Look, D. C., Tan, P., Shi, L., Hickey, M., Gakhar, L., et al. (2009). Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L84-L96. doi: 10.1152/ajplung.00071.2009
8. Kveiborg, M., Instrell, R., Rowlands, C., Howell, M., and Parker, P. J. (2011). PKCα and PKCδ regulate ADAM17-mediated ectodomain shedding of heparin binding-EGF through separate pathways. PLoS ONE 6:e17168. doi:10.1371/journal.pone.0017168
9. Lambert, D. W., Yarski, M., Warner, F. J., Thornhill, P., Parkin, E. T., Smith, A. I., et al. (2005). Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113-30119. doi: 10.1074/jbc. M505111200
10. Li, X., Pabla, N., Wei, Q., Dong, G., Messing, R. O., Wang, C. Y., et al. (2010). PKC-delta promotes renal tubular cell apoptosis associated with proteinuria. J. Am. Soc. Nephrol. 21, 1115-1124. doi: 10.1681/ASN.2009070760
11. Mizuiri, S., Aoki, T., Hemmi, H., Arita, M., Sakai, K., and Aikawa, A. (2011). Urinary angiotensin-converting enzyme 2 in patients with CKD. Nephrol (Carlton) 16, 567-572. doi: 10.1111/j.1440-1797.2011.01467.x
12. Murphy, G. (2009). Regulation of the proteolytic disintegrin metalloproteinases, the 'Sheddases'. Semin. Cell. Dev. Biol. 20, 138-145. doi: 10.1016/j.semcdb.2008.09.004
13. Nadarajah, R., Milagres, R., Dilauro, M., Gutsol, A., Xiao, F., Zimpelmann, J., et al. (2012). Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int. 82, 292-303. doi: 10.1038/ki.2012.83
14. Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., et al. (2010). Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes Metab. Res. Rev. 59, 529-538. doi: 10.2337/db09-1218
15. Pabla, N., Dong, G., Jiang, M., Huang, S., Kumar, M. V., Messing, R. O., et al. (2011). Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer. J. Clin. Invest. 121, 2709-2722. doi: 10.1172/JCI45586
16. Park, S. E., Kim, W. J., Park, S. W., Park, J. W., Lee, N., Park, C. Y., et al. (2013). High urinary ACE2 concentrations are associated with severity of glucose intolerance and microalbuminuria. Eur. J. Endocrinol. 168, 203-210. doi: 10.1530/EJE-12-0782
17. Parker, P. J., and Murray-Rust, J. (2004). PKC at a glance. J. Cell Sci. 117, 131-132. doi: 10.1242/jcs.00982
18. Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W., and Herzenberg, A. M. (2008). Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610-1616. doi: 10.1038/ki.2008.497
19. Sachse, A., and Wolf, G. (2007). Angiotensin II-induced reactive oxygen species and the kidney. J. Am. Soc. Nephrol. 18, 2439-2446. doi: 10.1681/ASN.2007020149
20. Salem, E. S., Grobe, N., and Elased, K. M. (2014). Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice. Am. J. Physiol. Renal Physiol. 306, F629-F639. doi: 10.1152/ajprenal.00516.2013
21. Santos, R. A., Simoese Silva, A. C., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., et al. (2003). Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl. Acad. Sci. U.S.A. 100, 8258-8263. doi: 10.1073/pnas.1432869100
22. Shaltout, H. A., Westwood, B. M., Averill, D. B., Ferrario, C. M., Figueroa, J. P., Diz, D. I., et al. (2007). Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II. Am. J. Physiol. Renal Physiol. 292, F82-F91. doi: 10.1152/ajprenal.00139.2006
23. Soler, M. J., Wysocki, J., Ye, M., Lloveras, J., Kanwar, Y., and Batlle, D. (2007). ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 72, 614-623. doi: 10.1038/sj.ki.5002373
24. Su, Z., Zimpelmann, J., and Burns, K. D. (2006). Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 69, 2212-2218. doi: 10.1038/sj.ki.5001509
25. Thabard, W., Collette, M., Bataille, R., and Amiot, M. (2001). Protein kinase c delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. Biochem. J. 358, 193-200. doi: 10.1042/bj3580193
26. Uchiyama, K., Saito, M., Sasaki, M., Obara, Y., Higashiyama, S., and Nakahata, N. (2009). Thromboxane A2 receptor-mediated epidermal growth factor receptor transactivation: involvement of PKC-delta and PKC-epsilon in the shedding of epidermal growth factor receptor ligands. Eur. J. Pharm. Sci. 38, 504-511. doi: 10.1016/j.ejps.2009.09.016
27. Warner, F. J., Lew, R. A., Smith, A. I., Lambert, D. W., Hooper, N. M., and Turner, A. J. (2005). Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. J. Biol. Chem. 280, 39353-39362. doi: 10.1074/jbc. M508914200
28. Wong, D. W., Oudit, G. Y., Reich, H., Kassiri, Z., Zhou, J., Liu, Q. C., et al. (2007). Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 171, 438-451. doi: 10.2353/ajpath.2007.060977
29. Wysocki, J., Garcia-Halpin, L., Ye, M., Maier, C., Sowers, K., Burns, K. D., et al. (2013). Regulation of urinary ACE2 in diabetic mice. Am. J. Physiol. Renal Physiol. 305, F600-F611. doi: 10.1152/ajprenal.00600.2012
30. Xia, H., Sriramula, S., Chhabra, K. H., and Lazartigues, E. (2013). Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension. Circ. Res. 113, 1087-1096. doi: 10.1161/CIRCRESAHA.113.301811
31. Xiao, F., Hiremath, S., Knoll, G., Zimpelmann, J., Srivaratharajah, K., Jadhav, D., et al. (2012). Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes. PLoS ONE 7:e37649. doi:10.1371/journal.pone.0037649
32. Xiao, F., Zimpelmann, J., Agaybi, S., Gurley, S. B., Puente, L., and Burns, K. D. (2014). Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells. PLoS ONE 9:e85958. doi: 10.1371/journal.pone.0085958